Drug Profile
Mesocarb - Melior Pharmaceuticals
Alternative Names: Armesocarb; MLR-1019Latest Information Update: 28 Apr 2023
Price :
$50
*
At a glance
- Originator Melior Discovery
- Developer Melior Pharmaceuticals, Inc.
- Class Antiparkinsonians; Imines; Oxadiazoles; Sleep disorder therapies; Small molecules
- Mechanism of Action Dopamine uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Parkinson's disease
- Preclinical Sleep disorders
- Market Withdrawal Psychiatric disorders